conversely, lowering blood glucose concentrations lowers oxidative stress (7,8)
Why Dose Increases Matter for GLP-1s When it comes to GLP-1 dose titration, semaglutide and tirzepatide are gradually ramped up for two distinct reasons: To give your body time to adapt to any side effects
Homeostasis of innate lymphoid cells is imbalanced in psoriatic arthritis
Starting at 1.0 mg significantly increases the risk of nausea, vomiting, and other gastrointestinal side effects
The Zepbound prescribing information explicitly states "initiate at 2.5 mg once weekly" with no exception for prior GLP-1 use
And the oral GLP-1 era is going global: the EMA recommended the Wegovy pill for EU approval in May, with Novo planning launches in select markets outside the US in the second half of 2026, while Lilly has submitted Foundayo for approval in more than 40 countries and plans to launch in each market shortly after regulatory clearance